First patient dosed in tumour membrane immunotherapy trial
November 15, 2021Sales and Marketing
Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumour membrane immunotherapy, announced that …
Biogen’s Aduhelm shown to reduce clinical decline in Alzheimer’s disease
November 12, 2021Medical Communications
New ADUHELM (aducanumab-avwa) Phase III data has shown a positive correlation between plasma p-tau reduction and less cognitive and functional …
Blood pressure drugs could protect against type 2 diabetes
November 12, 2021Medical Communications
Researchers have found that blood pressure drugs may directly reduce people’s risk of type 2 diabetes, a condition that an …
Trial investigates whether immunosuppressant holiday boosts vaccine protection
November 12, 2021Medical Communications
A trial has been launched to evaluate how to increase COVID-19 vaccine protection among vulnerable patients taking immunosuppressant drugs . …
Kintor Pharma begins Phase II trial of KX-826 for androgenetic alopecia treatment
November 12, 2021Medical Communications
Kintor Pharma, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company has dosed the …
New experimental drug identified for pancreatic cancer treatment
November 11, 2021Business Services
Professor Shudong Wang, Head of Drug Discovery and Development at the University of South Australia, is hoping to utilise the …
NICE recommends mogamulizumab for treatment of ultra-rare blood cancers
November 11, 2021Business Services
NICE has recommended POTELIGEO (mogamulizumab), manufactured by Kyowa Kirin, as a treatment option for adults in England in Wales with …
Study shows cancer treatments could be repurposed as Alzheimer’s drugs
November 11, 2021Business Services
A new study published in Science Advances has shared that cancer drugs can be repurposed as therapies to be tested …
New study confirms role of digital biomarkers in monitoring patients with multiple sclerosis
November 11, 2021Business Services
Results from a clinical study, published by Ad Scientiam in ‘Multiple Sclerosis and Related Disorders, secure the place of MSCopilot ® for the …
Pfizer ask FDA to authorise COVID booster in adults
November 10, 2021Research and Development
Pfizer have requested that the FDA authorise booster shots of the COVID-19 vaccine in all Americans 18 and older, citing …
COMPASS Pathways announce positive results in clinical trial for treatment-resistant depression
November 10, 2021Research and Development
COMPASS Pathways, a mental health care company dedicated to the acceleration of patient access to evidence-based innovation in mental health, …
Pleco Therapeutics partners with Hyloris to develop novel cancer agent
November 10, 2021Research and Development
Specialty biopharma company, Pleco Therapeutics, have announced the beginning of a strategic collaboration with Hyloris Pharmaceuticals, to develop and commercialise …
UK government to add Bharat Biotech’s Covaxin to list of approved travel vaccines
November 9, 2021Manufacturing and Production
The UK government has stated that Covaxin is to be added to its list of approved COVID-19 vaccines for international …
Harvard researchers target specific cells with gene therapy
November 9, 2021Manufacturing and Production
A new technique to turn therapeutic genes on in specifically targeted cells has been developed, a potential game-changer in the …
Regeneron’s COVID antibody drug provides long term protection in clinical trial
November 9, 2021Manufacturing and Production
Regeneron Pharmaceuticals have said that a single dose of its antibody COVID cocktail reduces the risk of contracting the virus …
BIAL appoints Joerg Holenz as R&D General Manager
November 8, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments
BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …
Diabetes drug dapagliflozin recommended by NICE for chronic kidney disease
November 8, 2021Sales and Marketing
A study published in the journal Lancet states that a common diabetes drug may be an option for treating chronic …
HLB’s liver cancer treatment awarded Orphan Drug Status by FDA
November 8, 2021Sales and Marketing
HLB have announced that its anticancer drug candidate, rivoceranib, has been awarded Orphan Drug Status by the FDA. HLB is …
UK government to roll out Merck antiviral pill, Pfizer COVID pill cuts hospitalisations by 89%
November 8, 2021Sales and Marketing
The UK government will roll out Merck’s COVID-19 antiviral pill, molnupiravir, through drug trial later this month. In early November, …
FDA decline Emergency Use Authorisation for ZYESAMI® in patients with critical COVID
November 5, 2021Medical Communications
The FDA has declined to grant Emergency Use Authorisation for NRx Pharmaceuticals’ therapy, Zyesami® (aviptadil), in the treatment of critical …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
